In absence seizures, the person may appear to be staring into space with or without jerking or twitching movements of the eye muscles. These periods last for seconds, or even tens of seconds. Those experiencing absence seizures sometimes move from one location to another without any purpose. Under normal circumstances thalamocortical oscillations maintain normal consciousness of an individual, however in certain circumstances the normal pattern can become disrupted; thereby leading to an episode of absence. Drugs, such as ethosuximide work by binding to t-type Ca2+ channels on thalamic neurones to modify these oscillations and prevent these episodes from occurring.
Epilepsy is the most common cause of recurrent seizures, where seizures are single events that reoccur with seemingly random frequency. Single seizures can be caused by blows to the head, fever (febrile seizure), reactions to medications, tumours, or as a symptom of a larger disease, among other causes.
Just as there are many different kinds of seizures, there are many different kinds of epilepsy. Doctors have identified hundreds of different epilepsy syndromes - disorders characterized by a specific set of symptoms that include epilepsy. Some of these syndromes appear to be hereditary. For other syndromes, the cause is unknown. Epilepsy syndromes are frequently described by their symptoms or by where in the brain they originate. People should discuss the implications of their type of epilepsy with their doctors to understand the full range of symptoms, the possible treatments, and the prognosis.
These seizures can happen a few times a day or in some cases hundreds of times a day, to the point that the person cannot concentrate in school or other situations requiring sustained, concentrated attention. Childhood absence epilepsy may stop when the child reaches puberty. Absence seizures usually have no lasting effect on intelligence or other brain function.
It is well known that bright lights, nervous, stressful, uncomfortable situations, or other strong sensory stimuli may trigger seizures. Hyperventilation is also a common trigger. However, loud noises can help to either bring a person back to consciousness or keep him or her conscious. Reciting one's name can be very helpful in an emergency as can repetitively asking the victim to "stay with you". Such can be accomplished by counting methods, alphabets and so on.
A person having an absence seizure shows no emotional expressions during the absent period. While the ability to express emotion in the face may be dissociated from the experience of emotion, the lack of any emotionally charged facial expression may indicate that a certain level of consciousness and arousal are needed to experience emotions.
A bilateral synchronous, symmetrical 3-Hz spike-and-wave discharge EEG pattern accompanies absence seizures.
The purpose of medication for treatment of absence seizures is to accomplish the goals above, by eliminating or reducing the frequency of the absence seizures, without causing side-effects more serious than the epilepsy itself.
Certain anticonvulsant drugs are used to minimize the number of seizures episodes. Absence seizures appear to respond well to divalproex sodium (trade name: Depakote), ethosuximide (trade name: Zarontin), and lamotrigine (Lamictal). Each of these medications has potential side effects, some of them possibly serious, which makes it important that the patient and/or their caregivers understand the specific medication they have been prescribed.
For treatment of absence seizures there is insufficient evidence to know if any of the available medications is best. i.e., which has the best combination of safety and efficacy for a particular patient. Nor is it known how long medication must be continued before an off-medication trial should be conducted to determine if the individual has outgrown the absence seizures, as is often the case with children.
To date, there have been no published results of any large, double-blind, placebo-controlled studies comparing the efficacy and safety of these or any other medications for absence seizures.
The U.S. government is currently sponsoring such a study. The purpose of this study is to determine the best initial treatment for childhood absence epilepsy from among valproic acid, ethosuximide and lamotrigine. In addition, the researchers hope to develop methods that may be used in the future to help choose the best medicine for each child diagnosed with absence seizures. The 5-year study began in 2004, and is expected to involve more than 400 children.
Also included in the study will be pharmacokinetics and pharmacogenetics research. Pharmacokinetics is the study of how the body absorbs, distributes, metabolizes, and excretes drugs. Pharmacogenetics is the study of genetic determinants of the response to drugs. Knowledge gained from this study may lead to individualized treatment for children with absence seizures.
Patent Issued for Composition for the Prevention and Treatment of Absence Seizures Comprising PKC Agonist as an Effective Ingredient
Dec 05, 2012; By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the...
US Patent Issued to Korea Institute of Science and Technology on Nov. 20 for "Composition for the Prevention and Treatment of Absence Seizures Comprising Pkc Agonist as an Effective Ingredient" (South Korean Inventors)
Nov 26, 2012; ALEXANDRIA, Va., Nov. 26 -- United States Patent no. 8,313,744, issued on Nov. 20, was assigned to Korea Institute of Science and...